Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
LYRFIGTU
NDANot in Orange Book
LIRAFUGRATINIB HYDROCHLORIDE | N220425 | ELEVAR
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (2)
Sort:
#001 — EQ 20MG BASE
▴
CAPSULE;ORAL | Approved: Sep. 23, 2026
Patents (2)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
11780845Newly listed — daily FDA feed, not yet in monthly Orange Book edition
May 12, 2040
—
Yes
Yes
—
—
12152034Newly listed — daily FDA feed, not yet in monthly Orange Book edition